ABSTRACT
OBJECTIVE: This study was conducted to elucidate the predictive value of hematological indices, the neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and mean platelet volume (MPV), to determine the clinical outcome of placental abruption in women regarding stillbirth. METHODS: This retrospective review of medical charts was performed in a tertiary center experienced for maternal, fetal, and neonatal care, including 89 pregnant women with placental abruption with or without stillbirth. The results of the hemogram tests with hematological indices, including the NLR, PLR, and MPV, which are the routinely obtained parameters both at admission and 4 h postoperatively, were correlated with other clinical parameters. RESULTS: The findings showed that although there were remarkable changes in some of the clinical features of women with placental abruption with or without stillbirth, in general, the study groups were found comparable regarding these variables. The values of NLR, PLR, and MPV in women with stillbirth presented remarkable changes when hemogram tests were used as pre-operative and post-operative laboratory examinations, although these changes did not correlate with each other meaningfully. CONCLUSION: Stillbirth is one of the most important complications of placental abruption requiring rapid diagnosis and regular follow-up after its surgical management. To fine-tune emergent management of placental abruption in women with stillbirth, the indices of NLR, PLR, and MPV calculated at the first admission as well as during follow-up of the patients have clinical value as easily obtainable laboratory findings like other hematological parameters.
ABSTRACT
ABSTRACT BACKGROUND: Coronavirus disease 2019 (COVID-19) may be asymptomatic or symptomatic in pregnant women. Compared to non-pregnant reproductive-aged women, symptomatic individuals appear to have a higher risk of acquiring severe illness sequelae. OBJECTIVES: We assessed the clinical and laboratory characteristics and outcomes of pregnant COVID-19 patients unvaccinated for severe acute respiratory syndrome coronavirus 2 according to the trimester of pregnancy. DESIGN AND SETTING: This was a retrospective observational study conducted in a tertiary-level hospital in Turkey. METHODS: This retrospective study reviewed the clinical and laboratory characteristics and outcomes of 445 pregnant COVID-19 patients hospitalized during the first, second, and third trimesters of pregnancy and 149 other pregnant women as controls in a tertiary center from April 2020 to December 2021. All participants were unvaccinated. RESULTS: Overall, the study groups were comparable in terms of baseline clinical pregnancy characteristics. There was no clear difference among the study participants with COVID-19 in the first, second, and third trimesters of pregnancy. However, a considerably high number of clinical and laboratory findings revealed differences that were consistent with the inflammatory nature of the disease. CONCLUSIONS: The study results reveal the importance of careful follow-up of hospitalized cases as a necessary step by means of regular clinical and laboratory examinations in pregnant COVID-19 patients. With further studies, after implementing vaccination programs for COVID-19 in pregnant women, these data may help determine the impact of vaccination on the outcomes of pregnant COVID-19 patients.
ABSTRACT
BACKGROUND: Coronavirus disease 2019 (COVID-19) may be asymptomatic or symptomatic in pregnant women. Compared to non-pregnant reproductive-aged women, symptomatic individuals appear to have a higher risk of acquiring severe illness sequelae. OBJECTIVES: We assessed the clinical and laboratory characteristics and outcomes of pregnant COVID-19 patients unvaccinated for severe acute respiratory syndrome coronavirus 2 according to the trimester of pregnancy. DESIGN AND SETTING: This was a retrospective observational study conducted in a tertiary-level hospital in Turkey. METHODS: This retrospective study reviewed the clinical and laboratory characteristics and outcomes of 445 pregnant COVID-19 patients hospitalized during the first, second, and third trimesters of pregnancy and 149 other pregnant women as controls in a tertiary center from April 2020 to December 2021. All participants were unvaccinated. RESULTS: Overall, the study groups were comparable in terms of baseline clinical pregnancy characteristics. There was no clear difference among the study participants with COVID-19 in the first, second, and third trimesters of pregnancy. However, a considerably high number of clinical and laboratory findings revealed differences that were consistent with the inflammatory nature of the disease. CONCLUSIONS: The study results reveal the importance of careful follow-up of hospitalized cases as a necessary step by means of regular clinical and laboratory examinations in pregnant COVID-19 patients. With further studies, after implementing vaccination programs for COVID-19 in pregnant women, these data may help determine the impact of vaccination on the outcomes of pregnant COVID-19 patients.
Subject(s)
COVID-19 , Pregnancy Complications, Infectious , Female , Humans , Pregnancy , Adult , SARS-CoV-2 , Retrospective Studies , Pregnancy Trimester, Third , Pregnant Women , Pregnancy Complications, Infectious/epidemiologyABSTRACT
OBJECTIVE: The authors present a surgical film for vulvar cancer surgery, which was performed via video endoscopy. METHODS: An 88-yearold woman with squamous cell carcinoma of the vulva and who underwent radical vulvectomy was treated with sentinel lymph node (SLN) and bilateral inguinofemoral lymphadenectomy, which is preferably performed via video endoscopic surgery with a near-infrared fluorescence video endoscopy system. SLN mapping was performed using indocyanine green and near-infrared fluorescence mapping. RESULTS: SLNs were detected in the left superficial inguinal area. The surgeons performed bilateral inguinofemoral lymphadenectomy. CONCLUSION: No postoperative early or late complications developed, and the patient was discharged 7 days after surgery. Stage 1B vulvar cancer was identified.
